CG Oncology and Roche to Collaborate on Clinical Trial of Oncolytic Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications

IRVINE, Calif.--(BUSINESS WIRE)-- #biotech--CG Oncology and Roche to Collaborate on Trial of Oncolytic Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications

Click to view original post